Skopos Labs, Inc. Bio N Tech Se Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Skopos Labs, Inc. holds 234 shares of BNTX stock, worth $26,076. This represents 0.0% of its overall portfolio holdings.
Number of Shares
234
Previous 150
56.0%
Holding current value
$26,076
Previous $17,000
23.53%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
336Shares Held
39.9MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$909 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$475 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$451 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$211 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$201 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...